Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice

Brain Research

Volumn 869, Issue 1-2, 2000, Pages 241-243

  Agnello, D ^a   Villa, P ^a,b   Ghezzi, P ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0034733804     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02392-1     Document Type: Article

References (19)

1. Aderka D., Le J., Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:1989;3517-3523.
2. Aggarwal B.B., Khor W.J., Hass P.E., Moffat B., Spencer S.A., Henzel J., Bringman S., Nedwin G.E., Goeddel D.V., Harkins R.N. Human tumor necrosis factor. Production, purification and characterization. J. Biol. Chem. 260:1985;2345-2354.
3. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:1998;3299-3306.
4. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., Coffman R.L. Transgenic interleukin-10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189:1999;1005-1010.
5. de Waal-Malefyt R., Abrams J., Bennet B., Figdor C., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
6. Di Santo E., Alonzi T., Poli V., Fattori E., Toniatti C., Sironi M., Ricciardi-Castagnoli P., Ghezzi P. Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6 deficient mice. Cytokine. 9:1997;300-306.
7. Di Santo E., Sironi M., Pozzi P., Gnocchi P., Isetta A.M., Delvaux A., Goldman M., Marchant A., Ghezzi P. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 b production in the brain without affecting the activation of the hypothalamus-pituitary adrenal axis. Neuroimmunomodulation. 2:1995;149-154.
8. Faggioni R., Fantuzzi G., Villa P., Buurman W., van Tits L.J.H., Ghezzi P. Independent down-regulation of central versus peripheral TNF by LPS tolerance. Infect. Immun. 63:1995;1473-1477.
9. Fantuzzi G., Di Santo E., Sacco S., Benigni F., Ghezzi P. Role of the hypothalamus-pituitary-adrenal axis in the regulation of tumor necrosis factor production in mice: effect of stress and inhibition of endogenous glucocorticoids. J. Immunol. 155:1995;3552-3555.
10. Fantuzzi G., Ghezzi P. Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases. Mediators Inflamm. 2:1993;263-270.
11. Grilli M., Casati C., Barbieri I., Basudev H., Brusa R., Lozza G., Ongini E. Interleukin-10 gene disruption makes mice more susceptible to cerebral ischemia (abstract). Pharmacol. Res. 39:(Suppl.):1999;44.
12. Koedel U., Bernatowicz A., Frei K., Fontana A., Pfister H.W. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J. Immunol. 157:1996;5185-5191.
13. Lipton J.M., Macaluso A., Hitz M.E., Catania A. Central administration of the peptide alpha-MSH inhibits inflammation in the skin. Peptides. 12:1991;795-798.
14. Sacco S., Agnello D., Sottocorno M., Lozza G., Monopoli A., Villa P., Ghezzi P. Non-steroidal antiinflammatory drugs (NSAID) increase TNF production in the periphery but not in the central nervous system. J. Neurochem. 71:1998;2063-2070.
15. Samoilova E.B., Horton J.L., Chen Y. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Cell. Immunol. 188:1998;118-124.
16. Sironi M., Breviario F., Proserpio P., Biondi A., Vecchi A., Van Damme J., Dejana E., Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142:1989;549-553.
17. 2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression. Infect. Immun. 57:1989;2837-2841.
18. Spera P.A., Ellison J.A., Feuerstein G.Z., Barone F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251:1998;189-192.
19. Steinman L. Some misconceptions about understanding autoimmunity through experiments with knockouts. J. Exp. Med. 185:1997;2039-2041.